Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Non-alcoholic fatty liver disease in 2016
Sarah Townsend,
Philip N Newsome
Immunology and Immunotherapy
Research output
:
Contribution to journal
›
Article
›
peer-review
47
Citations (Scopus)
467
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Non-alcoholic fatty liver disease in 2016'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Phase II Trial
50%
Liver Disease
50%
Pathophysiology
25%
Weight Loss
25%
Clinical Outcomes
25%
CCR2
25%
Insulin Resistance
25%
Meta-analysis
25%
Liver Transplantation
25%
Common Cause
25%
Fibrosis
25%
Management Strategy
25%
Metabolic Syndrome
25%
Nonalcoholic Steatohepatitis
25%
Article Analysis
25%
Best Management Practices
25%
Obesity Resistance
25%
Review Analysis
25%
Patient Progress
25%
Glucagon-like
25%
Obeticholic Acid
25%
Weight Treatment
25%
Elafibranor
25%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Liver Disease
66%
Non-Alcoholic Fatty Liver Disease
66%
Pathophysiology
33%
Meta-Analysis
33%
Liver Transplantation
33%
Fibrosis
33%
Insulin Resistance
33%
Metabolic Syndrome
33%
Glucagon Like Peptide 1
33%
Obeticholic Acid
33%
Elafibranor
33%